AUA Summit - Tratamiento para el cáncer de próstata hormonosensible (CPHS) Lo que debe saber

SYSTEM UPGRADE NOTICE

We have made some exciting digital upgrades! All members and customers will need to reset their passwords to access their accounts in our new system. Doing so will allow you to complete transactions and access all AUA websites, including UrologyHealth.org, The Journal of Urology® and AUAUniversity, as well as all mobile apps. Reset your password now.

Centro de recursos Patient Magazine Podcast Donate

Tratamiento para el cáncer de próstata hormonosensible (CPHS) Lo que debe saber

Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Tratamiento para el cáncer de próstata hormonosensible (CPHS) Lo que debe saber

Tratamiento para el cáncer de próstata hormonosensible (CPHS) Lo que debe saber

El cáncer de próstata hormonosensible (CPHS) es un tipo de cáncer de próstata que es sensible a la hormonoterapia. Este tratamiento funciona bloqueando la producción de las hormonas androgénicas. Los altos niveles de andrógenos aumentan el riesgo de padecer cáncer de próstata. Las hormonoterapias son tratamientos que pueden demorar el avance del cáncer de próstata. (Treatment for Hormone Sensitive Prostate Cancer (HSPC) - What You Should Know Fact Sheet)